Anonymous ID: c33fa2 June 23, 2021, 11:49 a.m. No.65607   🗄️.is 🔗kun   >>5641 >>5671 >>5677

U.S. SEC chair provides more detail on new disclosure rules, Treasury market reform

 

The U.S. Securities and Exchange Commission (SEC) may require public companies to publish data on a whole range of new areas, including greenhouse gas emissions, workforce turnover and diversity, as its new chairman looks to enhance the SEC's disclosure regime.

 

Gary Gensler, SEC chair, told a financial services industry audience during the annual London City Week he has also asked staff to consider potential requirements for companies that have made "forward-looking" climate commitments and have significant operations in foreign jurisdictions with required climate-related targets. "I've asked staff to propose recommendations for the commission's consideration on human capital disclosure. This builds on past agency work and could include a number of metrics, such as workforce turnover, skills and development training, compensation, benefits, workforce demographics including diversity, and health and safety," Gensler said.

 

Gensler has already said the agency plans to introduce new climate-related and human capital rules as it steps up environmental, social and governance (ESG) disclosure and last week closed a public consultation on a potential new rule. read more His comments on Wednesday provide the clearest preview of what a rule would mandate when it is proposed, likely in October, based on the SEC's public agenda. Investor groups have asked the agency for more corporate disclosures on climate change and human capital, while business interests have pushed back, Reuters has reported. Gensler also said he had asked staff to explore structural changes to the U.S. Treasury cash and repo markets which have experienced a handful of liquidity crunches in recent years.

 

While the Federal Reserve has previously suggested introducing central clearing was an option to help grease the wheels of the Treasury market, Gensler said he had asked staff to "consider the potential benefits" of clearing -- signaling a potential shakeup for the world's largest market long term.

https://www.reuters.com/business/sustainable-business/sec-considers-disclosure-mandate-range-climate-metrics-2021-06-23/

Anonymous ID: c33fa2 June 23, 2021, 12:39 p.m. No.65632   🗄️.is 🔗kun   >>5641 >>5671 >>5677

'''US Treasuries: 10-year yield stalls below 1.5%; reverse repo hits another record-

 

Ten-year Treasury yields inched higher but remained below 1.5% in muted trading on Wednesday, one day after Federal Reserve Chairman Jerome Powell reaffirmed in congressional testimony the central bank's view that rising inflation will likely be temporary. "We will not raise interest rates pre-emptively because we fear the possible onset of inflation. We will wait for evidence of actual inflation or other imbalances," Powell said in a hearing before a U.S. House of Representatives panel.

Fed Governor Michelle Bowman and Atlanta Federal Reserve Bank President Raphael Bostic echoed the central bank's sentiment that high inflation will be temporary as the economy settles back to normal after the coronavirus pandemic, though above-average inflation may last longer than originally thought. "Temporary is going to be a little longer than we expected initially. ... Rather than it being two to three months, it may be six to nine months," Bostic said in an interview on National Public Radio's "Morning Edition." At their meeting last week, Fed officials surprised many market participants with a more hawkish tone and suggested that the central bank may raise interest rates as soon as 2023. The Treasury auctioned $61 billion in five-year notes Wednesday afternoon with a yield of 0.904%, the highest since February 2020.

The Fed's reverse repurchase window took in a record $813.6 billion in cash from 73 counterparties, a sign investors see few attractive options available in a low-yield environment. The benchmark 10-year Treasury yield rose to 1.4869%, while shorter-term 2-year yields edged higher to 0.2621%. Long duration 30-year Treasury yields inched up to 2.1104%.

https://www.reuters.com/article/usa-bonds/treasuries-10-year-yield-stalls-below-1-5-reverse-repo-hits-another-record-idUSL2N2O5291

https://apps.newyorkfed.org/markets/autorates/tomo-results-display?SHOWMORE=TRUE&startDate=01/01/2000&enddate=01/01/2000

 

They did one earlier than the big one with very small amount-see cap#2 bottom of "This is a small value exercise for operational readiness testing."

Anonymous ID: c33fa2 June 23, 2021, 12:45 p.m. No.65635   🗄️.is 🔗kun

>>65634

If he was drone anon......

owe each other beers....fucked up on one of the sets of pics with wrong island name but they were chill bout it

as mentioned talked to that one much during that.

Anonymous ID: c33fa2 June 23, 2021, 1:33 p.m. No.65649   🗄️.is 🔗kun   >>5671 >>5677

Regeneron Pharmaceuticals sold by President and Chief Science Officer: $43.11m-June 21

 

from yesterday

Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron

 

Amgen’s high-profile PCSK9 patent fight with Sanofi and Regeneron has attracted a who’s who of biopharma observers over the years, with many top companies voicing support for each side. Now, Amgen has suffered its third consecutive loss in the case. In a Monday order (PDF), the U.S. Court of Appeals for the Federal Circuit declined Amgen's request for a rehearing of a prior patent loss on PCSK9 cholesterol drug Repatha. With the decision, Amgen can either try to appeal further or drop the issue. A spokesman didn't immediately respond to a request for comment. The case stems back to 2014, when Amgen sued partners Sanofi and Regeneron over alleged PCSK9 patent infringement. Amgen asked the court to back broader patent protections on antibody drugs such as its PCSK9 drug Repatha. Without broader protections, Amgen and other companies have argued, me-too drugs can come in and make minor changes to a successful medicine without committing resources to research.

https://www.fiercepharma.com/pharma/amgen-dealt-another-blow-closely-watched-pcsk9-patent-case-against-sanofi-regeneron

 

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates. Number of employees : 9 123 people.

https://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/company/

George Yancopoulos is the chief scientific officer of biotech firm Regeneron. He received his M.D. and Ph.D. from Columbia University and became a professor of biology by age 28. Regeneron was cofounded by now-billionaire Leonard Schleifer in 1988. Yancopoulos joined the next year. Yancopoulos led the invention of seven approved drugs and a technology platform designed to invent more. Yancopoulos owns about 2% of Regeneron stock. Yancopoulos was the first pharmaceutical research chief to become a billionaire. Yancopoulos was a finalist in the Westinghouse Science Talent Search in 1976. Today, its called the Regeneron Science Talent Search and is sponsored by his company

https://www.forbes.com/profile/george-yancopoulos/

https://finviz.com/insidertrading.ashx?oc=1226690&tc=7&b=2

Anonymous ID: c33fa2 June 23, 2021, 2:08 p.m. No.65667   🗄️.is 🔗kun   >>5671 >>5677

Cindy McCain to be nominated for ambassador to United Nations food and agriculture programs

 

President Biden announced Wednesday he will nominate Cindy McCain, the widow of former Arizona Senator John McCain, for an ambassadorship to United Nations’ food and agriculture programs. If confirmed, McCain, who crossed party lines to endorse Biden in the general election, will head to Rome as the envoy to the United Nations Agencies for Food and Agriculture, which encompasses three U.N. agencies.

 

Biden also tapped Claire Cronin, a state representative in Massachusetts, to serve as ambassador to Ireland, a significant posting in the Biden administration given the president’s Irish heritage. Cronin is currently the majority leader in the Massachusetts House of Representatives, and she is the first woman to hold that role.

 

Biden often talks about his Irish roots, whether sharing stories about his ancestors or professing his love for Irish poets.

 

“Everything between Ireland and the United States runs deep,” Biden said while hosting a virtual visit with Ireland’s taoiseach on St. Patrick’s Day this year. “Our joys, our sorrows, our passion, our drive, our unrelenting optimism and hope.”

 

McCain and Cronin are part of the second group of Biden’s political ambassadors. Last week, the president announced his first slate, which included Tom Nides for Israel, Ken Salazar for Mexico and Sully Sullenberger for an aviation posting.

https://www.msn.com/en-us/news/politics/cindy-mccain-to-be-nominated-for-ambassador-to-united-nations-food-and-agriculture-programs/ar-AALmzT2

Anonymous ID: c33fa2 June 23, 2021, 2:18 p.m. No.65668   🗄️.is 🔗kun   >>5671 >>5677

FWIW Korean President Moon was in Barcelona on 0616 after a visit to Vienna,Austria these both after the G-7 meetings at Cornwall

Left the next day

Anonymous ID: c33fa2 June 23, 2021, 2:34 p.m. No.65670   🗄️.is 🔗kun   >>5671 >>5677

Biden administration forces head of Border Patrol to leave post immediately

 

The Biden administration is forcing out the career law enforcement official overseeing the U.S. Border Patrol and will temporarily replace him with the second in command, the Washington Examiner has learned.

 

Border Patrol Chief Rodney Scott informed regional chiefs from around the country in a video conference Wednesday of his plans to leave, according to three people with knowledge of the conversation. Homeland Security Secretary Alejandro Mayorkas made the final decision to get rid of Scott, all three people said.

 

One person said the move was not related to Scott's performance over the past 18 months or how he has handled the surge of people coming across the southern border since President Joe Biden took office. Instead, the move was “completely driven by politics," even though Scott's position is apolitical and he is a 29-year law enforcement official at the Border Patrol.

 

"This is unprecedented," said the first person. Scott was given what Border Patrol agents refer to as the "three R letter," which stands for resign, retire, or relocate. Scott did not respond to a request for comment about his departure. In a post to his personal Facebook page, Scott wrote that he had received his letter today asking him to leave his post.

 

"I received my 3R letter today. For those not familiar, that is Federal government slang for the letter issued to [Senior Executive Service] level employees informing them of a directed reassignment. The recipient has 3 options- relocate, resign, or retire. No rationale or reason is required, nor is it disciplinary," Scott wrote.

 

"Just a simple needs of the service directed reassignment so the new administration can place the person they want in the position," Scott continued. "A huge thank you to all those who have reached out, prayed and supported me and my family, especially over these last few crazy months. I remain confident that God is in control. And..... over 29 yrs is a pretty good run!"

 

The move comes five months into the Biden administration, while Border Patrol's parent agency, U.S. Customs and Border Protection, has struggled to get a leader confirmed by the Senate. Biden nominated Tucson Police Chief Chris Magnus for the job in mid-April. Magnus's department came under scrutiny last June for how officers restrained a Hispanic man. The man, Carlos Ingram-Lopez, died while in police custody.

 

A second person familiar with internal considerations about Magnus's nomination said the administration is considering moving him to be Border Patrol chief because he would not need to get congressional approval to work in that position.

 

"They forced Bob Perez out, too," the first person said, referring to the CBP deputy commissioner. "These are both career officials."

 

CBP and DHS did not respond to requests for comment.

https://www.washingtonexaminer.com/news/head-of-border-patrol-leaving-post